Loss of CLK4 reduces Nexilin phosphorylation and results in disrupted cytoskeletal anchoring, sarcomeric instability, and cardiac hypertrophy; restoration of the Nexilin phosphorylation has been shown to rescue the phenotype35. This evidence concerns the gene CLK4 and cardiac hypertrophy.